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Type-1 and type-2 diabetes is an affliction affecting 371 million people worldwide. To manage 
this disease, patients use insulin to lower their blood sugar levels. However, patients are unable 
to sense if their insulin has become deteriorated without sending the substance back to the 
manufacturer, adding costs to the manufacturer and patient. A spectrophotometer machine will 
evaluate insulin samples at specific wavelengths to demonstrate deterioration. A high 
performance liquid chromatography machine will then check these same insulin samples’ 
potency. These machines will be utilized in parallel to determine if they can effectively 
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 Insulin is a protein chain secreted from the pancreas’ beta cells in healthy humans and 
lowers blood sugar levels. Presently, hundreds of millions of patients depend on insulin 
injections to survive, and insulin production has become a $17 billion dollar industry worldwide. 
Before the 1980s, insulin was harvested from bovine, pigs, and other animals.  To meet the 
increasing diabetic population’s insulin demands, insulin is now a product of recombinant DNA 
technologies, which are capable of large-scale production. Predominantly, E Coli is genetically 
modified to secrete insulin [1].  
 
Figure 1: Amino acid sequence of insulin [2]  
Diabetes is a disease that affects the ability of insulin to maintain blood sugar levels. For 
a patient with type-two diabetes, the patient becomes insulin resistant and may need additional 
insulin injections to lower blood sugar levels if the disease worsens. Juvenile diabetics’, or type-
one diabetics’, own immune system will attack beta cells in the pancreas — beta cells store and 
secrete insulin — rendering the person with no self-synthesizing insulin system [3]. Due to this, 
type-one diabetics require insulin injections for life. 
Insulin is well documented as having an inconsistent effect due to fragile physical 
stabilities [2]. After exposed to excessive heat, shaking, or expiration, insulin’s ability to lower a 
diabetic’s blood sugar levels can become inhibited or nonexistent. Damaged insulin can be 
dangerous for an unsuspecting diabetic, who will assume the insulin will lower his/her blood 
sugar levels. This could lead to high blood sugar, which can result in ketoacidosis, coma, or 
death. There is currently no technology and no reliable process available outside of a lab setting 
to determine if insulin has become damaged. 
Literature suggests that damaged insulin has become unfolded and fibrillated. Fibrillation 
is the physical process by which partially unfolded insulin molecules interact with each other to 
form linear aggregates, which renders the insulin significantly weaker or ineffective for the 
patient [4]. Insulin’s polypeptide unfolding and fibrillation can be detected qualitatively using a 
spectrophotometer at specific wavelengths. For a normal insulin sample, a relatively low 
absorbance reading will be detected around 275 nm. For a fibrillated insulin sample, a relatively 
large absorbance reading will be detected around 275 nm [5]. 
To determine the concentration of the insulin, high performance liquid chromatography 
(HPLC) is ideal. The HPLC method is quick (less than two hours per sample), cheap, and is 
easily automated for continuous analysis. The animal response methods are expensive and time-
consuming. HPLC has been documented to give as accurate readings as animal response assays. 
In literature [6], a reversed-phase HPLC with a 75 x 4.6 mm i.d. column was packed with 
Ultrapore RPSC at ambient temperature. Mobile phase A was 0.05% (v/v) trifluoroacetic acid in 
water. Mobile phase B was 0.05% trifluoroacetic acid in acetonitrile-water (60:40, v/v). The 
gradient was linear from 40% B to 44% B in 30 min. The flow rate was 2 ml min-1, and detection 
was at 214 nm with a range setting of 0.2 a.u.f.s. Manufactured insulin peaked around 10 
minutes in this study, while fibrillated insulin peaked around 20 minutes [6]. 
By completing this research, it is plausible for a MEMS (microelectromechanical system) 
spectrophotometer biosensor or MEMS HPLC biosensor to be created that will detect insulin 
fibrillation. If such a sensor is created, diabetics will have an at-home solution to tell if their 




 We hypothesize that insulin deterioration detected by a spectrophotometer can be 




 Samples of Humalog, Lantus, Novolog, and Levemir with concentrations of 100 units per 
milliliter were obtained. Each insulin was tested in a spectrophotometer at five dilutions, and the 
absorbance readings of the peaks were recorded. These same samples were then analyzed by an 
HPLC to check the potency of each sample, which created a standard curve. As shown in Figure 
2, Novolog and Levemir have higher insulin concentrations than Lantus and Humalog. 
Therefore, the dilutions used for Novolog and Levemir were 20x, 40x, 80x, 160x, and 320x 
dilutions when constructing the standard curves, while Humalog and Lantus used 10x, 20x, 40x, 
80x, and 160x dilutions. All heated samples were diluted to a 20x dilution. 
 
 
Figure 2: The relative concentrations of the insulins were used to determine the dilutions 

























Three samples of each insulin type were then be placed into a hot water bath for 2 hours 
at 62 degrees Celsius. The heated samples were then tested in the spectrophotometer and HPLC. 
The spectrophotometer readings of the heated insulin samples were graphically compared to the 
normal insulin samples at 20x dilution. For the HPLC, mobile phase A composed of 0.05% (v/v) 
trifluoroacetic acid in water and mobile phase B composed of 0.05% trifluoroacetic acid in 
acetonitrile was used for Lantus. The three other insulins used mobile phase A composed of 
0.1% formic acid in water and mobile phase B composed of 0.1% formic acid in acetonitrile. The 
flow rate was 1.3 ml min-1, and the detection wavelength was at 280 nm for all insulins. From the 
linear standard curve created by the HPLC readings, the concentration of the heated insulins can 




 The results of each insulin type will be discussed, which includes the standard curves, 






 The standard curve for the Lantus insulin is shown in Figure 3.	
	
 




















From the three incubated samples, the average area is 83.9, which results in a 
concentration of 0.0991 mg/mL of insulin. This is a 45.5% reduction in the insulin concentration 
after heating. The spectrophotometer reading’s for the 20x heated Lantus and the 20x un-heated 
Lantus are shown in Figure 4. 
 
 
Figure 4: The incubated sample has a slightly higher peak than the normal sample. 
4.2 Humalog: 
 
 The standard curve for the Humalog insulin is shown in Figure 5. Please note that the 80x 



















Figure 5: The standard curve will be used to find the incubated Humalog’s concentration	
From the three incubated samples, the average area is 87.0, which results in a concentration of 
0.0980 mg/mL of insulin. This is a 44.0% reduction in the insulin concentration after heating. 
The spectrophotometer reading’s for the 20x heated Humalog and the 20x un-heated Humalog 


























Figure 6: The incubated sample has a lower peak than the normal sample. This may be due 
to outliers in the data. 
4.3 Levemir: 
 




















Figure 7: The standard curve will be used to find the incubated Levemir’s concentration	
From the three incubated samples, the average area is 65.7, which results in a concentration of 
0.404 mg/mL of insulin. This is a 43.2% reduction in the insulin concentration after heating. The 
spectrophotometer reading’s for the 20x heated Levemir and the 20x un-heated Levemir are 






















Figure 8: The incubated sample has a higher peak than the normal sample 
4.4 Novolog: 
 






















Figure 9: The standard curve will be used to find the incubated Levemir’s concentration 
From the three incubated samples, the average area is 38.6, which results in a concentration of 
0.389 mg/mL of insulin. This is a 51.4% reduction in the insulin concentration after heating. The 
spectrophotometer reading’s for the 20x heated Novolog and the 20x un-heated Novolog are 
























Figure 10: The incubated sample has a higher peak than the normal sample 
5. Conclusions and Future Work: 
 
The trend of a higher spectrophotometer peak at 270 nm and a lower insulin 
concentration was strongest for Levemir and Novolog. Humalog and Lantus had outliers in their 
spectrophotometer data that skewed the results lower. Therefore, it would be beneficial for future 
experiments to run more trials. The spike in absorbance in the spectrophotometer may have been 
due to oligopeptides resulting from the degrading insulin. These byproducts would not show up 
in the HPLC because all samples were filtered before entering the HPLC. Future experiments 
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